Need to purchase reprints? Click here to order
Am J Clin Nutr 90: 1343-1350, 2009. First published September 9, 2009; doi:10.3945/ajcn.2009.27543
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2009.27543
Vol. 90, No. 5, 1343-1350, November 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow All Versions of this Article:
90/5/1343    most recent
ajcn.2009.27543v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkes, E. A
Right arrow Articles by Rennie, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkes, E. A
Right arrow Articles by Rennie, M. J
Agricola
Right arrow Articles by Wilkes, E. A
Right arrow Articles by Rennie, M. J
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia1,2,3

Emilie A Wilkes, Anna L Selby, Philip J Atherton, Rekha Patel, Debbie Rankin, Ken Smith and Michael J Rennie

1 From the University of Nottingham, School of Graduate Entry Medicine and Health, Derby, United Kingdom (EAW, ALS, PJA, RP, DR, KS, and MJR).

2 Supported by grants from UK BBSRC (BB/X510697/1, BB/X510697/1, and BB/C516779/1) and from the EC EXEGENESIS program.

3 Address reprint requests and correspondence to MJ Rennie, University of Nottingham, School of Graduate Entry Medicine and Health, Derby City Hospital, Uttoxeter Road, Derby DE22 3DT, United Kingdom. E-mail: michael.rennie{at}nottingham.ac.uk.

Background: Reduced postprandial muscle proteolysis is mainly due to increased insulin availability. Whether rates of proteolysis in response to low physiologic doses of insulin are affected by aging is unknown.

Objectives: We tested the hypothesis that suppression of leg protein breakdown (LPB) by insulin is blunted in older subjects, together with blunted activation of Akt–protein kinase B (PKB).

Design: Groups of 8 young [mean (±SD) age: 24.5 ± 1.8 y] and older (65.0 ± 1.3 y) participants were studied during euglycemic (5 mmol/L), isoaminoacidemic (blood leucine {approx} 120 µmol/L) clamp procedures at plasma insulin concentrations of {approx}5 and {approx}15 µIU/mL for 1.5 h. Leg amino acid balance, whole-leg protein turnover (as dilution of amino acid tracers), and muscle protein synthesis were measured with D5-phenylalanine and [1,2-13C2]leucine. The kinase activity of muscle Akt-PKB and the extent of phosphorylation of signaling proteins associated with the mTOR (mammalian target of rapamycin) pathway were measured before and after the clamp procedures.

Results: Basal LPB rates were not different between groups (66 ± 11 compared with 51 ± 10 nmol leucine · 100 mL leg–1 · min–1 and 30 ± 5 compared with 24 ± 4 nmol phenylalanine · 100 mL leg–1 · min–1 in young and older groups, respectively). However, although insulin at {approx}15 µIU/mL lowered LPB by 47% in the young subjects (P < 0.05) and abolished the negative leg amino acid balance, this caused only a 12% fall (P > 0.05) in the older group. Akt-PKB activity mirrored decreases in LPB. No differences were seen in muscle protein synthesis or associated anabolic signaling phosphoproteins.

Conclusions: At moderate availability, the effect of insulin on LPB is diminished in older human beings, and this effect may be mediated through blunted Akt-PKB activation.




This article has been cited by other articles:


Home page
Br Med BullHome page
M. V. Narici and N. Maffulli
Sarcopenia: characteristics, mechanisms and functional significance
Br. Med. Bull., September 1, 2010; 95(1): 139 - 159.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. Perrini, L. Laviola, M. C. Carreira, A. Cignarelli, A. Natalicchio, and F. Giorgino
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis
J. Endocrinol., June 1, 2010; 205(3): 201 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. A. Greig, P. J. Atherton, and M. J. Rennie
Can an NSAID a day keep muscle wasting away?
J. Physiol., December 15, 2009; 587(24): 5799 - 5800.
[Full Text] [PDF]